Adage Capital Partners Portfolio holdings
AUM
$59.3B
This Quarter Return
+4.73%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$54B
AUM Growth
+$54B
(+2%)
Cap. Flow
+$2.71B
Cap. Flow
% of AUM
5.03%
Top 10 Holdings %
Top 10 Hldgs %
30.64%
Holding
972
New
111
Increased
256
Reduced
426
Closed
112
Top Buys
| 1 |
NVIDIA
NVDA
|
$2.63B |
| 2 |
HES
Hess
HES
|
$470M |
| 3 |
Exxon Mobil
XOM
|
$248M |
| 4 |
Hubbell
HUBB
|
$139M |
| 5 |
Costco
COST
|
$124M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
$281M |
| 2 |
Emerson Electric
EMR
|
$233M |
| 3 |
AbbVie
ABBV
|
$169M |
| 4 |
Amazon
AMZN
|
$167M |
| 5 |
RB Global
RBA
|
$165M |
Sector Composition
| 1 | Technology | 29.07% |
| 2 | Healthcare | 16.38% |
| 3 | Financials | 10.36% |
| 4 | Consumer Discretionary | 9.32% |
| 5 | Industrials | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
776
Navigator Holdings
NVGS
$1.08B
| $2.18M | ﹤0.01% |
+125,000
| New | +$2.18M |
|
777
Waters Corp
WAT
$17.5B
| $1.99M | ﹤0.01% |
6,865
-16,752
| -71% | -$4.86M |
|
778
Apogee Therapeutics
APGE
$2.29B
| $1.97M | ﹤0.01% |
50,000
-125,000
| -71% | -$4.92M |
|
779
Centuri Holdings
CTRI
$1.83B
| $1.95M | ﹤0.01% |
+100,000
| New | +$1.95M |
|
780
Alexandria Real Estate Equities
ARE
$13.7B
| $1.87M | ﹤0.01% |
16,000
-63,500
| -80% | -$7.43M |
|
781
Arcutis Biotherapeutics
ARQT
$1.87B
| $1.86M | ﹤0.01% |
+200,000
| New | +$1.86M |
|
782
Fulcrum Therapeutics
FULC
$349M
| $1.86M | ﹤0.01% |
300,000
-806,422
| -73% | -$5M |
|
783
Aligos Therapeutics
ALGS
$75.1M
| $1.75M | ﹤0.01% |
5,000,000
+2,535,495
| +103% | +$887K |
|
784
Option Care Health
OPCH
$4.64B
| $1.69M | ﹤0.01% |
61,000
+30,000
| +97% | +$831K |
|
785
Finance of America Companies
FOA
$300M
| $1.65M | ﹤0.01% |
3,342,883
| – | – |
|
|
IMA
786
ImageneBio, Inc. Common Stock
IMA
$150M
| $1.63M | ﹤0.01% |
987,900
+700,000
| +243% | +$1.16M |
|
|
ATYR
787
aTyr Pharma
ATYR
$557M
| $1.56M | ﹤0.01% |
+1,000,000
| New | +$1.56M |
|
788
Harmony Biosciences
HRMY
$2.13B
| $1.51M | ﹤0.01% |
50,000
-25,000
| -33% | -$754K |
|
789
Lifestance Health
LFST
$2.15B
| $1.47M | ﹤0.01% |
+300,000
| New | +$1.47M |
|
790
Arq
ARQ
$304M
| $1.46M | ﹤0.01% |
240,000
-320,000
| -57% | -$1.94M |
|
791
Werner Enterprises
WERN
$1.69B
| $1.45M | ﹤0.01% |
40,545
-70,000
| -63% | -$2.51M |
|
792
Braze
BRZE
$2.85B
| $1.36M | ﹤0.01% |
+35,000
| New | +$1.36M |
|
793
Rezolute
RZLT
$625M
| $1.36M | ﹤0.01% |
315,845
-315,845
| -50% | -$1.36M |
|
794
Blue Owl Capital
OWL
$11.8B
| $1.33M | ﹤0.01% |
75,000
+50,000
| +200% | +$888K |
|
795
Health Catalyst
HCAT
$234M
| $1.27M | ﹤0.01% |
198,963
| – | – |
|
796
Moog
MOG.A
$6.15B
| $1.26M | ﹤0.01% |
7,553
| – | – |
|
797
Graphic Packaging
GPK
$6.3B
| $1.2M | ﹤0.01% |
45,953
-280,000
| -86% | -$7.34M |
|
798
Alignment Healthcare
ALHC
$3.29B
| $1.09M | ﹤0.01% |
140,000
-200,000
| -59% | -$1.56M |
|
799
HilleVax
HLVX
$105M
| $1.07M | ﹤0.01% |
74,220
| – | – |
|
800
Scholar Rock
SRRK
$3.27B
| $1.04M | ﹤0.01% |
125,000
-400,000
| -76% | -$3.33M |
|